0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anti Rabies Serum Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-33F14756
Home | Market Reports | Health| Pharmacy
Global Anti Rabies Serum Market Research Report 2023
BUY CHAPTERS

Global Anti Rabies Serum Market Research Report 2025

Code: QYRE-Auto-33F14756
Report
May 2025
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Anti Rabies Serum Market

The global market for Anti Rabies Serum was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Anti-rabies serum is a biological product that is used to prevent and treat rabies infection. It is made from the blood of animals that have been immunized against the rabies virus. The serum contains antibodies that can neutralize the virus and prevent it from causing disease.
The development prospects of anti-rabies serum are promising. Advances in biotechnology and immunology have led to the development of new techniques for producing and purifying antibodies. These techniques have made it possible to produce high-quality anti-rabies serum that is safe and effective.
In addition, there is a growing demand for anti-rabies serum in many parts of the world, particularly in developing countries where rabies is still a major public health problem. This demand has led to increased investment in research and development of new anti-rabies serum products.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Anti Rabies Serum, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti Rabies Serum.
The Anti Rabies Serum market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti Rabies Serum market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti Rabies Serum manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Anti Rabies Serum Market Report

Report Metric Details
Report Name Anti Rabies Serum Market
Segment by Type
Segment by Application
  • Clinic
  • Hospital
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Haffkine Ajintha Pharmaceuticals, Bharat Serums and Vaccines, National Institutes of Health, Congruent Pharmachem, Shanghai Serum Bio-technology, Serum Institute of India, Premium Serums, LEXICARE PHARMA, Zydus Cadila Healthcare, VINS Bio-Products, Zydus Takeda Healthcare, BPL, Aventis Pasteur
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Anti Rabies Serum manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Anti Rabies Serum in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Anti Rabies Serum Market report?

Ans: The main players in the Anti Rabies Serum Market are Haffkine Ajintha Pharmaceuticals, Bharat Serums and Vaccines, National Institutes of Health, Congruent Pharmachem, Shanghai Serum Bio-technology, Serum Institute of India, Premium Serums, LEXICARE PHARMA, Zydus Cadila Healthcare, VINS Bio-Products, Zydus Takeda Healthcare, BPL, Aventis Pasteur

What are the Application segmentation covered in the Anti Rabies Serum Market report?

Ans: The Applications covered in the Anti Rabies Serum Market report are Clinic, Hospital

What are the Type segmentation covered in the Anti Rabies Serum Market report?

Ans: The Types covered in the Anti Rabies Serum Market report are Human Anti-rabies Immunoglobulin, Equine Anti-rabies Immunoglobulin

Recommended Reports

Rabies Related Markets

Immunology & Serum Markets

Anti-Infectives & Diagnostics

1 Anti Rabies Serum Market Overview
1.1 Product Definition
1.2 Anti Rabies Serum by Type
1.2.1 Global Anti Rabies Serum Market Value Comparison by Type (2024 VS 2031)
1.2.2 Human Anti-rabies Immunoglobulin
1.2.3 Equine Anti-rabies Immunoglobulin
1.3 Anti Rabies Serum by Application
1.3.1 Global Anti Rabies Serum Market Value by Application (2024 VS 2031)
1.3.2 Clinic
1.3.3 Hospital
1.4 Global Anti Rabies Serum Market Size Estimates and Forecasts
1.4.1 Global Anti Rabies Serum Revenue 2020-2031
1.4.2 Global Anti Rabies Serum Sales 2020-2031
1.4.3 Global Anti Rabies Serum Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Anti Rabies Serum Market Competition by Manufacturers
2.1 Global Anti Rabies Serum Sales Market Share by Manufacturers (2020-2025)
2.2 Global Anti Rabies Serum Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Anti Rabies Serum Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Anti Rabies Serum, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anti Rabies Serum, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti Rabies Serum, Product Type & Application
2.7 Global Key Manufacturers of Anti Rabies Serum, Date of Enter into This Industry
2.8 Global Anti Rabies Serum Market Competitive Situation and Trends
2.8.1 Global Anti Rabies Serum Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Anti Rabies Serum Players Market Share by Revenue
2.8.3 Global Anti Rabies Serum Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Anti Rabies Serum Market Scenario by Region
3.1 Global Anti Rabies Serum Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Anti Rabies Serum Sales by Region: 2020-2031
3.2.1 Global Anti Rabies Serum Sales by Region: 2020-2025
3.2.2 Global Anti Rabies Serum Sales by Region: 2026-2031
3.3 Global Anti Rabies Serum Revenue by Region: 2020-2031
3.3.1 Global Anti Rabies Serum Revenue by Region: 2020-2025
3.3.2 Global Anti Rabies Serum Revenue by Region: 2026-2031
3.4 North America Anti Rabies Serum Market Facts & Figures by Country
3.4.1 North America Anti Rabies Serum Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Anti Rabies Serum Sales by Country (2020-2031)
3.4.3 North America Anti Rabies Serum Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Anti Rabies Serum Market Facts & Figures by Country
3.5.1 Europe Anti Rabies Serum Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Anti Rabies Serum Sales by Country (2020-2031)
3.5.3 Europe Anti Rabies Serum Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti Rabies Serum Market Facts & Figures by Region
3.6.1 Asia Pacific Anti Rabies Serum Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Anti Rabies Serum Sales by Region (2020-2031)
3.6.3 Asia Pacific Anti Rabies Serum Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Anti Rabies Serum Market Facts & Figures by Country
3.7.1 Latin America Anti Rabies Serum Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Anti Rabies Serum Sales by Country (2020-2031)
3.7.3 Latin America Anti Rabies Serum Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anti Rabies Serum Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti Rabies Serum Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Anti Rabies Serum Sales by Country (2020-2031)
3.8.3 Middle East and Africa Anti Rabies Serum Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti Rabies Serum Sales by Type (2020-2031)
4.1.1 Global Anti Rabies Serum Sales by Type (2020-2025)
4.1.2 Global Anti Rabies Serum Sales by Type (2026-2031)
4.1.3 Global Anti Rabies Serum Sales Market Share by Type (2020-2031)
4.2 Global Anti Rabies Serum Revenue by Type (2020-2031)
4.2.1 Global Anti Rabies Serum Revenue by Type (2020-2025)
4.2.2 Global Anti Rabies Serum Revenue by Type (2026-2031)
4.2.3 Global Anti Rabies Serum Revenue Market Share by Type (2020-2031)
4.3 Global Anti Rabies Serum Price by Type (2020-2031)
5 Segment by Application
5.1 Global Anti Rabies Serum Sales by Application (2020-2031)
5.1.1 Global Anti Rabies Serum Sales by Application (2020-2025)
5.1.2 Global Anti Rabies Serum Sales by Application (2026-2031)
5.1.3 Global Anti Rabies Serum Sales Market Share by Application (2020-2031)
5.2 Global Anti Rabies Serum Revenue by Application (2020-2031)
5.2.1 Global Anti Rabies Serum Revenue by Application (2020-2025)
5.2.2 Global Anti Rabies Serum Revenue by Application (2026-2031)
5.2.3 Global Anti Rabies Serum Revenue Market Share by Application (2020-2031)
5.3 Global Anti Rabies Serum Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Haffkine Ajintha Pharmaceuticals
6.1.1 Haffkine Ajintha Pharmaceuticals Company Information
6.1.2 Haffkine Ajintha Pharmaceuticals Description and Business Overview
6.1.3 Haffkine Ajintha Pharmaceuticals Anti Rabies Serum Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Haffkine Ajintha Pharmaceuticals Anti Rabies Serum Product Portfolio
6.1.5 Haffkine Ajintha Pharmaceuticals Recent Developments/Updates
6.2 Bharat Serums and Vaccines
6.2.1 Bharat Serums and Vaccines Company Information
6.2.2 Bharat Serums and Vaccines Description and Business Overview
6.2.3 Bharat Serums and Vaccines Anti Rabies Serum Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bharat Serums and Vaccines Anti Rabies Serum Product Portfolio
6.2.5 Bharat Serums and Vaccines Recent Developments/Updates
6.3 National Institutes of Health
6.3.1 National Institutes of Health Company Information
6.3.2 National Institutes of Health Description and Business Overview
6.3.3 National Institutes of Health Anti Rabies Serum Sales, Revenue and Gross Margin (2020-2025)
6.3.4 National Institutes of Health Anti Rabies Serum Product Portfolio
6.3.5 National Institutes of Health Recent Developments/Updates
6.4 Congruent Pharmachem
6.4.1 Congruent Pharmachem Company Information
6.4.2 Congruent Pharmachem Description and Business Overview
6.4.3 Congruent Pharmachem Anti Rabies Serum Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Congruent Pharmachem Anti Rabies Serum Product Portfolio
6.4.5 Congruent Pharmachem Recent Developments/Updates
6.5 Shanghai Serum Bio-technology
6.5.1 Shanghai Serum Bio-technology Company Information
6.5.2 Shanghai Serum Bio-technology Description and Business Overview
6.5.3 Shanghai Serum Bio-technology Anti Rabies Serum Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Shanghai Serum Bio-technology Anti Rabies Serum Product Portfolio
6.5.5 Shanghai Serum Bio-technology Recent Developments/Updates
6.6 Serum Institute of India
6.6.1 Serum Institute of India Company Information
6.6.2 Serum Institute of India Description and Business Overview
6.6.3 Serum Institute of India Anti Rabies Serum Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Serum Institute of India Anti Rabies Serum Product Portfolio
6.6.5 Serum Institute of India Recent Developments/Updates
6.7 Premium Serums
6.7.1 Premium Serums Company Information
6.7.2 Premium Serums Description and Business Overview
6.7.3 Premium Serums Anti Rabies Serum Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Premium Serums Anti Rabies Serum Product Portfolio
6.7.5 Premium Serums Recent Developments/Updates
6.8 LEXICARE PHARMA
6.8.1 LEXICARE PHARMA Company Information
6.8.2 LEXICARE PHARMA Description and Business Overview
6.8.3 LEXICARE PHARMA Anti Rabies Serum Sales, Revenue and Gross Margin (2020-2025)
6.8.4 LEXICARE PHARMA Anti Rabies Serum Product Portfolio
6.8.5 LEXICARE PHARMA Recent Developments/Updates
6.9 Zydus Cadila Healthcare
6.9.1 Zydus Cadila Healthcare Company Information
6.9.2 Zydus Cadila Healthcare Description and Business Overview
6.9.3 Zydus Cadila Healthcare Anti Rabies Serum Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Zydus Cadila Healthcare Anti Rabies Serum Product Portfolio
6.9.5 Zydus Cadila Healthcare Recent Developments/Updates
6.10 VINS Bio-Products
6.10.1 VINS Bio-Products Company Information
6.10.2 VINS Bio-Products Description and Business Overview
6.10.3 VINS Bio-Products Anti Rabies Serum Sales, Revenue and Gross Margin (2020-2025)
6.10.4 VINS Bio-Products Anti Rabies Serum Product Portfolio
6.10.5 VINS Bio-Products Recent Developments/Updates
6.11 Zydus Takeda Healthcare
6.11.1 Zydus Takeda Healthcare Company Information
6.11.2 Zydus Takeda Healthcare Description and Business Overview
6.11.3 Zydus Takeda Healthcare Anti Rabies Serum Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Zydus Takeda Healthcare Anti Rabies Serum Product Portfolio
6.11.5 Zydus Takeda Healthcare Recent Developments/Updates
6.12 BPL
6.12.1 BPL Company Information
6.12.2 BPL Description and Business Overview
6.12.3 BPL Anti Rabies Serum Sales, Revenue and Gross Margin (2020-2025)
6.12.4 BPL Anti Rabies Serum Product Portfolio
6.12.5 BPL Recent Developments/Updates
6.13 Aventis Pasteur
6.13.1 Aventis Pasteur Company Information
6.13.2 Aventis Pasteur Description and Business Overview
6.13.3 Aventis Pasteur Anti Rabies Serum Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Aventis Pasteur Anti Rabies Serum Product Portfolio
6.13.5 Aventis Pasteur Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti Rabies Serum Industry Chain Analysis
7.2 Anti Rabies Serum Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti Rabies Serum Production Mode & Process Analysis
7.4 Anti Rabies Serum Sales and Marketing
7.4.1 Anti Rabies Serum Sales Channels
7.4.2 Anti Rabies Serum Distributors
7.5 Anti Rabies Serum Customer Analysis
8 Anti Rabies Serum Market Dynamics
8.1 Anti Rabies Serum Industry Trends
8.2 Anti Rabies Serum Market Drivers
8.3 Anti Rabies Serum Market Challenges
8.4 Anti Rabies Serum Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Anti Rabies Serum Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Anti Rabies Serum Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Anti Rabies Serum Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Anti Rabies Serum Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Anti Rabies Serum Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Anti Rabies Serum Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Anti Rabies Serum Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Anti Rabies Serum Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Anti Rabies Serum, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Anti Rabies Serum, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Anti Rabies Serum, Product Type & Application
 Table 12. Global Key Manufacturers of Anti Rabies Serum, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Anti Rabies Serum by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti Rabies Serum as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Anti Rabies Serum Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Anti Rabies Serum Sales by Region (2020-2025) & (K Units)
 Table 18. Global Anti Rabies Serum Sales Market Share by Region (2020-2025)
 Table 19. Global Anti Rabies Serum Sales by Region (2026-2031) & (K Units)
 Table 20. Global Anti Rabies Serum Sales Market Share by Region (2026-2031)
 Table 21. Global Anti Rabies Serum Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Anti Rabies Serum Revenue Market Share by Region (2020-2025)
 Table 23. Global Anti Rabies Serum Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Anti Rabies Serum Revenue Market Share by Region (2026-2031)
 Table 25. North America Anti Rabies Serum Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Anti Rabies Serum Sales by Country (2020-2025) & (K Units)
 Table 27. North America Anti Rabies Serum Sales by Country (2026-2031) & (K Units)
 Table 28. North America Anti Rabies Serum Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Anti Rabies Serum Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Anti Rabies Serum Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Anti Rabies Serum Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Anti Rabies Serum Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Anti Rabies Serum Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Anti Rabies Serum Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Anti Rabies Serum Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Anti Rabies Serum Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Anti Rabies Serum Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Anti Rabies Serum Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Anti Rabies Serum Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Anti Rabies Serum Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Anti Rabies Serum Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Anti Rabies Serum Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Anti Rabies Serum Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Anti Rabies Serum Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Anti Rabies Serum Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Anti Rabies Serum Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Anti Rabies Serum Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Anti Rabies Serum Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Anti Rabies Serum Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Anti Rabies Serum Sales (K Units) by Type (2020-2025)
 Table 51. Global Anti Rabies Serum Sales (K Units) by Type (2026-2031)
 Table 52. Global Anti Rabies Serum Sales Market Share by Type (2020-2025)
 Table 53. Global Anti Rabies Serum Sales Market Share by Type (2026-2031)
 Table 54. Global Anti Rabies Serum Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Anti Rabies Serum Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Anti Rabies Serum Revenue Market Share by Type (2020-2025)
 Table 57. Global Anti Rabies Serum Revenue Market Share by Type (2026-2031)
 Table 58. Global Anti Rabies Serum Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Anti Rabies Serum Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Anti Rabies Serum Sales (K Units) by Application (2020-2025)
 Table 61. Global Anti Rabies Serum Sales (K Units) by Application (2026-2031)
 Table 62. Global Anti Rabies Serum Sales Market Share by Application (2020-2025)
 Table 63. Global Anti Rabies Serum Sales Market Share by Application (2026-2031)
 Table 64. Global Anti Rabies Serum Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Anti Rabies Serum Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Anti Rabies Serum Revenue Market Share by Application (2020-2025)
 Table 67. Global Anti Rabies Serum Revenue Market Share by Application (2026-2031)
 Table 68. Global Anti Rabies Serum Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Anti Rabies Serum Price (US$/Unit) by Application (2026-2031)
 Table 70. Haffkine Ajintha Pharmaceuticals Company Information
 Table 71. Haffkine Ajintha Pharmaceuticals Description and Business Overview
 Table 72. Haffkine Ajintha Pharmaceuticals Anti Rabies Serum Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Haffkine Ajintha Pharmaceuticals Anti Rabies Serum Product
 Table 74. Haffkine Ajintha Pharmaceuticals Recent Developments/Updates
 Table 75. Bharat Serums and Vaccines Company Information
 Table 76. Bharat Serums and Vaccines Description and Business Overview
 Table 77. Bharat Serums and Vaccines Anti Rabies Serum Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Bharat Serums and Vaccines Anti Rabies Serum Product
 Table 79. Bharat Serums and Vaccines Recent Developments/Updates
 Table 80. National Institutes of Health Company Information
 Table 81. National Institutes of Health Description and Business Overview
 Table 82. National Institutes of Health Anti Rabies Serum Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. National Institutes of Health Anti Rabies Serum Product
 Table 84. National Institutes of Health Recent Developments/Updates
 Table 85. Congruent Pharmachem Company Information
 Table 86. Congruent Pharmachem Description and Business Overview
 Table 87. Congruent Pharmachem Anti Rabies Serum Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Congruent Pharmachem Anti Rabies Serum Product
 Table 89. Congruent Pharmachem Recent Developments/Updates
 Table 90. Shanghai Serum Bio-technology Company Information
 Table 91. Shanghai Serum Bio-technology Description and Business Overview
 Table 92. Shanghai Serum Bio-technology Anti Rabies Serum Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Shanghai Serum Bio-technology Anti Rabies Serum Product
 Table 94. Shanghai Serum Bio-technology Recent Developments/Updates
 Table 95. Serum Institute of India Company Information
 Table 96. Serum Institute of India Description and Business Overview
 Table 97. Serum Institute of India Anti Rabies Serum Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Serum Institute of India Anti Rabies Serum Product
 Table 99. Serum Institute of India Recent Developments/Updates
 Table 100. Premium Serums Company Information
 Table 101. Premium Serums Description and Business Overview
 Table 102. Premium Serums Anti Rabies Serum Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Premium Serums Anti Rabies Serum Product
 Table 104. Premium Serums Recent Developments/Updates
 Table 105. LEXICARE PHARMA Company Information
 Table 106. LEXICARE PHARMA Description and Business Overview
 Table 107. LEXICARE PHARMA Anti Rabies Serum Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. LEXICARE PHARMA Anti Rabies Serum Product
 Table 109. LEXICARE PHARMA Recent Developments/Updates
 Table 110. Zydus Cadila Healthcare Company Information
 Table 111. Zydus Cadila Healthcare Description and Business Overview
 Table 112. Zydus Cadila Healthcare Anti Rabies Serum Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Zydus Cadila Healthcare Anti Rabies Serum Product
 Table 114. Zydus Cadila Healthcare Recent Developments/Updates
 Table 115. VINS Bio-Products Company Information
 Table 116. VINS Bio-Products Description and Business Overview
 Table 117. VINS Bio-Products Anti Rabies Serum Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. VINS Bio-Products Anti Rabies Serum Product
 Table 119. VINS Bio-Products Recent Developments/Updates
 Table 120. Zydus Takeda Healthcare Company Information
 Table 121. Zydus Takeda Healthcare Description and Business Overview
 Table 122. Zydus Takeda Healthcare Anti Rabies Serum Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Zydus Takeda Healthcare Anti Rabies Serum Product
 Table 124. Zydus Takeda Healthcare Recent Developments/Updates
 Table 125. BPL Company Information
 Table 126. BPL Description and Business Overview
 Table 127. BPL Anti Rabies Serum Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. BPL Anti Rabies Serum Product
 Table 129. BPL Recent Developments/Updates
 Table 130. Aventis Pasteur Company Information
 Table 131. Aventis Pasteur Description and Business Overview
 Table 132. Aventis Pasteur Anti Rabies Serum Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Aventis Pasteur Anti Rabies Serum Product
 Table 134. Aventis Pasteur Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Anti Rabies Serum Distributors List
 Table 138. Anti Rabies Serum Customers List
 Table 139. Anti Rabies Serum Market Trends
 Table 140. Anti Rabies Serum Market Drivers
 Table 141. Anti Rabies Serum Market Challenges
 Table 142. Anti Rabies Serum Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Anti Rabies Serum
 Figure 2. Global Anti Rabies Serum Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Anti Rabies Serum Market Share by Type: 2024 & 2031
 Figure 4. Human Anti-rabies Immunoglobulin Product Picture
 Figure 5. Equine Anti-rabies Immunoglobulin Product Picture
 Figure 6. Global Anti Rabies Serum Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Anti Rabies Serum Market Share by Application: 2024 & 2031
 Figure 8. Clinic
 Figure 9. Hospital
 Figure 10. Global Anti Rabies Serum Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Anti Rabies Serum Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Anti Rabies Serum Sales (2020-2031) & (K Units)
 Figure 13. Global Anti Rabies Serum Average Price (US$/Unit) & (2020-2031)
 Figure 14. Anti Rabies Serum Report Years Considered
 Figure 15. Anti Rabies Serum Sales Share by Manufacturers in 2024
 Figure 16. Global Anti Rabies Serum Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Anti Rabies Serum Players: Market Share by Revenue in Anti Rabies Serum in 2024
 Figure 18. Anti Rabies Serum Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Anti Rabies Serum Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Anti Rabies Serum Sales Market Share by Country (2020-2031)
 Figure 21. North America Anti Rabies Serum Revenue Market Share by Country (2020-2031)
 Figure 22. United States Anti Rabies Serum Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Anti Rabies Serum Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Anti Rabies Serum Sales Market Share by Country (2020-2031)
 Figure 25. Europe Anti Rabies Serum Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Anti Rabies Serum Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Anti Rabies Serum Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Anti Rabies Serum Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Anti Rabies Serum Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Anti Rabies Serum Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Anti Rabies Serum Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Anti Rabies Serum Revenue Market Share by Region (2020-2031)
 Figure 33. China Anti Rabies Serum Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Anti Rabies Serum Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Anti Rabies Serum Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Anti Rabies Serum Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Anti Rabies Serum Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Anti Rabies Serum Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Anti Rabies Serum Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America Anti Rabies Serum Sales Market Share by Country (2020-2031)
 Figure 41. Latin America Anti Rabies Serum Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico Anti Rabies Serum Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil Anti Rabies Serum Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina Anti Rabies Serum Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Middle East and Africa Anti Rabies Serum Sales Market Share by Country (2020-2031)
 Figure 46. Middle East and Africa Anti Rabies Serum Revenue Market Share by Country (2020-2031)
 Figure 47. Turkey Anti Rabies Serum Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Anti Rabies Serum Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. UAE Anti Rabies Serum Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Global Sales Market Share of Anti Rabies Serum by Type (2020-2031)
 Figure 51. Global Revenue Market Share of Anti Rabies Serum by Type (2020-2031)
 Figure 52. Global Anti Rabies Serum Price (US$/Unit) by Type (2020-2031)
 Figure 53. Global Sales Market Share of Anti Rabies Serum by Application (2020-2031)
 Figure 54. Global Revenue Market Share of Anti Rabies Serum by Application (2020-2031)
 Figure 55. Global Anti Rabies Serum Price (US$/Unit) by Application (2020-2031)
 Figure 56. Anti Rabies Serum Value Chain
 Figure 57. Channels of Distribution (Direct Vs Distribution)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart